In the high-risk subgroup, median survival was 149 months for female patients and 130 months for male patients, though this difference did not reach statistical significance (p = 0.185), likely due to sample size limitations.
← all excerpts
Unique Gender-Related Characteristics and Differences of Chronic Myeloid Leukemia Patients in Azerbaijan: A Retrospective Cohort Study.
1
0.1850
0.1850